Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05052333 · ClinicalTrials.gov registry record
Examine the Psychosocial Impacts of COVID-19 Pandemic.
A clinical trial of COVID-19 Pandemic and Psychosocial Impacts, sponsored by University of Otago.
- Completed
- Registry status
- 2,574
- Enrollment target
- 9
- Study locations
NCT05052333 is a study of COVID-19 Pandemic and Psychosocial Impacts that has completed, run by University of Otago. The registered enrollment target is 2,574 participants, above the 310-participant average among 3 other COVID-19 Pandemic trials with a reported enrollment target (730% higher). The trial reports 9 study locations across 2 states.
The verdict
NCT05052333, a study of COVID-19 Pandemic and Psychosocial Impacts, has completed, sponsored by University of Otago.
- COMPLETED
- Registry status
- 2,574 participants
- Enrollment target
- 9
- Study locations
Study Summary
This is an observational study examining the psychosocial impacts of the COVID-19 pandemic in seven low-and-middle income countries (Indonesia, Iran, Iraq, Malaysia, Pakistan, Somaliland, and Turkiye). The data was obtained on standardised measures of wellbeing (WHO Well-Being Index), psychological distress (Kessler 10), post-traumatic stress (PTSD Checklist for DSM-5), post-traumatic growth (Posttraumatic Growth Inventory), and a novel pandemic-related stress (COVID Psychosocial Impacts Scale). Data was collected employing either a unilingual (in native language) or bilingual online survey (with English as a second language) from participants (N=2574) aged 18 and above using a non-probability convenient sampling. The findings enabled us to examine the psychosocial impacts of COVID-19, validate the translations of the CPIS and standardized measures; and determine the trajectory of study variables with pandemic exposure.
Conditions Studied
Study Locations (9)
Other
- Universitas Ahmad Dahlan - Yogyakarta
- Universitas Gadjah Mada - Yogyakarta
- University of Social Welfare and Rehabilitation Sciences - Tehran
- Ibn Sina University of Medical and Pharmaceutical Sciences - Baghdad
- Mustansiriyah University - Baghdad
- Universiti Malaya - Kuala Lumpur
- International Islamic University - Islamabad
- Hasan Kalyoncu Üniversitesi - Gaziantep
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,574 participants |
| Start Date | 2021-12-01 |
| Est. Completion | 2023-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05052333
The ClinicalTrials.gov registry entry for NCT05052333 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,574 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 310-participant average among 3 other COVID-19 Pandemic trials with a reported enrollment target (730% higher). The listed sponsor is University of Otago, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with COVID-19 Pandemic appearing as the primary indexed condition, and to 0 interventions.
NCT05052333 reports 9 study locations spanning 2 distinct geographic areas - top geographies include Other, Washington.
Frequently Asked Questions
What is clinical trial NCT05052333 about?
NCT05052333 is a clinical study titled "Examine the Psychosocial Impacts of COVID-19 Pandemic.". This is an observational study examining the psychosocial impacts of the COVID-19 pandemic in seven low-and-middle income countries (Indonesia, Iran, Iraq, Malaysia, Pakistan, Somaliland, and Turkiye). The data was obtained on standardised measures of wellbeing (WHO Well-Being Index), psychological ...
What is the current status of trial NCT05052333?
This trial is currently completed. The enrollment target is 2,574 participants. The study started on 2021-12-01. Estimated completion is 2023-10-31.
What conditions does trial NCT05052333 study?
This clinical trial studies the following conditions: COVID-19 Pandemic, Psychosocial Impacts.
Who is sponsoring clinical trial NCT05052333?
This trial is sponsored by University of Otago, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05052333 being conducted?
This trial has 9 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19 Pandemic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.